ginsenoside rh2 has been researched along with Leukemia in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 7 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, DL; Chen, Y; Jiang, R; Li, HX; Li, J; Liu, ZH; Shi, XP; Wang, F; Xiong, W | 1 |
| Fang, JP; Lao, CH; Wang, JC; Xia, T; Xu, LH; Xu, W; Ye, QX | 1 |
| Chen, D; Li, D; Li, J; Wei, Q; Xia, J; You, Z; Zhao, L | 1 |
| Chen, DL; Chen, Y; Jiang, R; Li, J; Li, XP; Liu, ZH; Xia, J; Xiong, W; Zuo, GW | 1 |
| Chen, DL; Chen, Y; Li, J; Li, KQ; Li, XP; Liu, ZH; Xia, J; Xiong, W | 1 |
| Huang, J; Li, J; Luo, T; Luo, Z; Peng, K; Su, M; Wang, L; Wen, B; Zhou, L | 1 |
| Cho, SH; Choi, JH; Choi, SY; Chung, KS; Hong, HD; Kim, DH; Lee, KT; Rhee, YK; Shin, JS | 1 |
7 other study(ies) available for ginsenoside rh2 and Leukemia
| Article | Year |
|---|---|
[Ginsenoside Rh₂-induced inhibition of histone deacetylase 6 promotes K562 cells autophagy and apoptosis in vivo].
Topics: Animals; Apoptosis; Autophagy; Drugs, Chinese Herbal; Enzyme Inhibitors; Female; Ginsenosides; Histone Deacetylase 1; Histone Deacetylase 6; Histone Deacetylases; Humans; K562 Cells; Leukemia; Mice, Inbred BALB C; Repressor Proteins | 2016 |
20S-Ginsenoside Rh2 induces apoptosis in human Leukaemia Reh cells through mitochondrial signaling pathways.
Topics: Annexin A5; Antineoplastic Agents, Phytogenic; Apoptosis; Caspase 3; Caspase 9; Cell Line, Tumor; Cytochromes c; Dose-Response Relationship, Drug; Drugs, Chinese Herbal; Ginsenosides; Humans; Leukemia; Membrane Potential, Mitochondrial; Mitochondria; Panax; Phytotherapy; Signal Transduction | 2014 |
[Ginsenoside Rh2 inhibits proliferation and promotes apoptosis of leukemia KG1-α cells].
Topics: Apoptosis; Blotting, Western; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cyclin D1; Cyclin-Dependent Kinase Inhibitor p21; Dose-Response Relationship, Drug; Drugs, Chinese Herbal; Flow Cytometry; Ginsenosides; Humans; Inhibitory Concentration 50; Leukemia; Time Factors; Tumor Suppressor Protein p53 | 2014 |
Ginsenoside 20(s)-Rh2 as potent natural histone deacetylase inhibitors suppressing the growth of human leukemia cells.
Topics: Acetylation; Animals; Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Proliferation; Cell Survival; Gene Expression Regulation, Neoplastic; Ginsenosides; Histone Acetyltransferases; Histone Deacetylase Inhibitors; Histone Deacetylases; Histones; Humans; K562 Cells; Leukemia; Male; MAP Kinase Signaling System; Mesenchymal Stem Cells; Mice | 2015 |
20(S)-ginsenoside Rh2 inhibits the proliferation and induces the apoptosis of KG-1a cells through the Wnt/β-catenin signaling pathway.
Topics: Antineoplastic Agents; Apoptosis; Basic Helix-Loop-Helix Leucine Zipper Transcription Factors; beta Catenin; Cell Line, Tumor; Cell Proliferation; Cyclin D1; Drugs, Chinese Herbal; Flow Cytometry; G1 Phase Cell Cycle Checkpoints; Ginsenosides; Humans; Leukemia; Microscopy, Electron, Transmission; Panax; Real-Time Polymerase Chain Reaction; Transcription Factor 4; Transcription Factor RelA; Transcription Factors; Wnt Proteins; Wnt Signaling Pathway | 2016 |
Ginsenoside Rh2 inhibits proliferation and induces apoptosis in human leukemia cells via TNF-α signaling pathway.
Topics: Apoptosis; Caspases; Cell Proliferation; G1 Phase; Ginsenosides; HL-60 Cells; Humans; Leukemia; Tumor Necrosis Factor-alpha | 2016 |
Ginsenoside Rh2 induces cell cycle arrest and differentiation in human leukemia cells by upregulating TGF-β expression.
Topics: Apoptosis; Blotting, Western; Cell Cycle Checkpoints; Cell Cycle Proteins; Cell Differentiation; Cell Proliferation; Drugs, Chinese Herbal; G1 Phase; Ginsenosides; Humans; Immunoprecipitation; Leukemia; Phosphorylation; Real-Time Polymerase Chain Reaction; Retinoblastoma Protein; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Transforming Growth Factor beta; Tumor Cells, Cultured | 2013 |